These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 646367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J, Bost R, Carpentier P, Franco A, Fournet J.
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Paroxysmal dysarthria and Raynaud's phenomenon in the tongue.
    Nielsen HV, Kristensen JK, Klemp P, Staberg B, Thomsen K.
    Acta Med Scand; 1984 Feb; 216(4):431-2. PubMed ID: 6516913
    [Abstract] [Full Text] [Related]

  • 5. Association between Raynaud's phenomenon and migraine in a random population of hospital employees.
    O'Keeffe ST, Tsapatsaris NP, Beetham WP.
    J Rheumatol; 1993 Jul; 20(7):1187-8. PubMed ID: 8371215
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Analysis of Raynaud's phenomenon in systemic scleroderma: comparative study with that in vibration disease].
    Maeda M, Shikano Y, Mori S.
    Nihon Hifuka Gakkai Zasshi; 1989 Nov; 99(12):1255-9. PubMed ID: 2622060
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E, Letizia C, Proietti M, Aversa A, Menghi G, Rossi C, Torella E, Cotesta D, Petramala L, Bruzziches R, Spera G, Pisarri S, Salsano F.
    J Biol Regul Homeost Agents; 2009 Nov; 23(1):23-9. PubMed ID: 19321043
    [Abstract] [Full Text] [Related]

  • 13. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A, Del Puente A, Farinaro C, Scarpa R, Oriente P, Rocco P, Gioia M.
    Clin Ther; 1987 Nov; 9(2):232-7. PubMed ID: 3568066
    [Abstract] [Full Text] [Related]

  • 14. Raynaud's phenomenon and systemic sclerosis.
    Generini S, Kahaleh B, Matucci-Cerinic M, Pignone A, Lombardi A, Ohtsuka T.
    Ann Ital Med Int; 1996 Nov; 11(2):125-31. PubMed ID: 8974438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P.
    Rev Prat; 1998 Oct 01; 48(15):1659-64. PubMed ID: 9814067
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.